--Smaller 6mm Diameter and Other Product Enhancements are Designed to Increase Patient Comfort and Improve Physician Ease-of-Use-- MARLBOROUGH, Massachusetts, Nov. 14, 2016 /PRNewswire/ --Hologic, Inc ...
Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...
April 12 (Reuters) - Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva ...
MARLBOROUGH, Mass. — Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, has announced approval of the NovaSure ® V5 global endometrial ablation (GEA) device in Canada and Europe. This ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Court of Appeals for the Federal Circuit unanimously affirmed a 2021 district court ruling that ...
MARLBOROUGH, Massachusetts, Nov. 14, 2016 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) today announced the launch of its next-generation NovaSure ® 6mm global endometrial ablation (GEA) system, the ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback